Treprostinil Sodium
CAS 81846-19-7 8 FDA-DMF suppliersSmall Molecule
Overview
Treprostinil Sodium is a stable salt form of treprostinil, a synthetic analogue of prostacyclin, which acts as a potent vasodilator. It is primarily used for the treatment of pulmonary arterial hypertension to improve exercise ability and delay clinical worsening.
API suppliers (2)
Suppliers of Treprostinil Sodium backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- EUROFINS CDMO ALPHORA INCCanada1 active DMF
- EUROFINS CDMO ALPHORA INCCanada1 active DMF
Therapeutic areas
Cardiovascular DiseasesPulmonary Hypertension
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.